These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects. Kumar M; Yadav AK; Verma V; Singh B; Mal G; Nagpal R; Hemalatha R Future Microbiol; 2016; 11(4):585-600. PubMed ID: 27070955 [TBL] [Abstract][Full Text] [Related]
3. Bacterial vectors and delivery systems in cancer therapy. Gardlik R; Fruehauf JH IDrugs; 2010 Oct; 13(10):701-6. PubMed ID: 20878592 [TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. Bacterial vectors for imaging and cancer gene therapy: a review. Cronin M; Stanton RM; Francis KP; Tangney M Cancer Gene Ther; 2012 Nov; 19(11):731-40. PubMed ID: 22996740 [TBL] [Abstract][Full Text] [Related]
7. New strategies for cancer gene therapy: progress and opportunities. Cao S; Cripps A; Wei MQ Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):108-14. PubMed ID: 19671071 [TBL] [Abstract][Full Text] [Related]
8. Probiotics and prebiotics in human health. Saier MH; Mansour NM J Mol Microbiol Biotechnol; 2005; 10(1):22-5. PubMed ID: 16491023 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy for cancer: dairy bacteria as delivery vectors. Tangney M Discov Med; 2010 Sep; 10(52):195-200. PubMed ID: 20875340 [TBL] [Abstract][Full Text] [Related]
11. Use of bacteria in anti-cancer therapies. Ryan RM; Green J; Lewis CE Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949 [TBL] [Abstract][Full Text] [Related]
12. Development of bacterial vectors for tumor-targeted gene therapy. Jia LJ; Hua ZC Methods Mol Biol; 2009; 542():131-54. PubMed ID: 19565900 [TBL] [Abstract][Full Text] [Related]
13. Bacteria in gene therapy: bactofection versus alternative gene therapy. Pálffy R; Gardlík R; Hodosy J; Behuliak M; Resko P; Radvánský J; Celec P Gene Ther; 2006 Jan; 13(2):101-5. PubMed ID: 16163379 [TBL] [Abstract][Full Text] [Related]
14. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465 [TBL] [Abstract][Full Text] [Related]
15. Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria. Vaks L; Benhar I Methods Mol Biol; 2011; 726():187-206. PubMed ID: 21424451 [TBL] [Abstract][Full Text] [Related]
16. How science will help shape future clinical applications of probiotics. Reid G Clin Infect Dis; 2008 Feb; 46 Suppl 2():S62-6; discussion S144-51. PubMed ID: 18181725 [TBL] [Abstract][Full Text] [Related]
17. Bacteria in the treatment of cancer. Lin J; Lin E; Nemunaitis J Curr Opin Mol Ther; 2004 Dec; 6(6):629-39. PubMed ID: 15663328 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy. Gardlik R; Behuliak M; Palffy R; Celec P; Li CJ Gene Ther; 2011 May; 18(5):425-31. PubMed ID: 21228886 [TBL] [Abstract][Full Text] [Related]
19. Current status of polymeric gene delivery systems. Park TG; Jeong JH; Kim SW Adv Drug Deliv Rev; 2006 Jul; 58(4):467-86. PubMed ID: 16781003 [TBL] [Abstract][Full Text] [Related]
20. Targeted gene therapy: frontiers in the development of 'smart drugs'. Tarner IH; Müller-Ladner U; Fathman CG Trends Biotechnol; 2004 Jun; 22(6):304-10. PubMed ID: 15158060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]